AEBSF產(chǎn)品描述:AEBSF is an irreversible serine protease inhibitor, and inhibits proteases like chymotrypsin, kallikrein, plasmin, thrombin, and trypsin.In Vitro: AEBSF inhibits the constitutive production of Aβ by directly inhibiting β-secretase in five different human cell lines, both neural and nonneural[1]. AEBSF, as a serine protease inhibitor, inhibits the lysis of leukemic cells by human macrophages without inhibiting macrophage secretion of TNF-α and IL-1β[2]. AEBSF also disturbs the growth of blastocysts on endometrial cells and inhibit the adhesion of HeLa cells on HUVECs by altering the protein secretion pattern[4]. In Vivo: AEBSF (76.8 mg/kg daily, i.p.) results in prolongation of the survival of mice that have been given a lethal T. gondii infection[3]. AEBSF also reduces airway response and underlying inflammation in cockroach allergen-induced murine model[4]. 公司介紹:MedChemExpress(MCE)專注于各種抑制劑、激動(dòng)劑、API及化合物庫,總部位于美國新澤西,分別在瑞典和上海設(shè)有歐洲區(qū)子公司和亞洲區(qū)總代理,營銷網(wǎng)點(diǎn)遍及全球20多個(gè)國家地區(qū)。MCE經(jīng)過多年努力已成為全球生物活性小分子領(lǐng)域的一流供應(yīng)商, 產(chǎn)品涵蓋癌癥、神經(jīng)科學(xué)、抗感染、表觀遺傳學(xué)等20個(gè)熱門研究領(lǐng)域,PI3K、MAPK等近千個(gè)細(xì)分靶點(diǎn),超過4000個(gè)活性小分子化合物現(xiàn)貨,以及GPCR、API、離子通道等超過20種不同類型的化合物庫,同時(shí)提供從毫克到千克的專業(yè)定制合成服務(wù)。 MCE 對每批產(chǎn)品都進(jìn)行嚴(yán)格的LCMS和NMR檢驗(yàn),其產(chǎn)品已被全球近萬名客戶廣泛使用并發(fā)表大量文章、專利; MCE 定期增加各領(lǐng)域熱門抑制劑、激動(dòng)劑,不斷擴(kuò)增已有化合物庫,以滿足最新的科研需求; 數(shù)千種產(chǎn)品在上海有充足備貨,24-48小時(shí)內(nèi)送達(dá)客戶; 大量產(chǎn)品提供免費(fèi)試用裝;已為全球多個(gè)知名企業(yè)、院校構(gòu)建各種定制型化合物庫。 產(chǎn)品鏈接:www.medchemexpress.cn/aebsf.html |
AEBSF研究進(jìn)展
發(fā)布日期:2017-11-01 瀏覽次數(shù):0
核心提示:a href=https://www.medchemexpress.com/AEBSF.htmlAEBSF/a產(chǎn)品描述:AEBSF is an irreversible bserine protease/b inhibitor,
行業(yè)動(dòng)態(tài)
更多...
- ATN-161 (trifluoroacetat 11-06
- AZM475271研究進(jìn)展 11-06
- AVN-944研究進(jìn)展 11-06
- Ascomycin研究進(jìn)展 11-06
- β-Lapachone研究進(jìn)展 11-06
- Anidulafungin研究進(jìn)展 11-06
- Amsacrine (hydrochloride 11-06
- Amsacrine研究進(jìn)展 11-06
- Uramustine研究進(jìn)展 11-06
- Exherin (trifluoroacetat 11-06